Leukemia, T-cell, Chronic - 25 Studies Found
Completed |
: Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia : Leukemia, T-Cell : 2004-11-03 : Drug: forodesine hydrochloride (BCX-1777) |
Completed |
: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma :
: 2004-04-23 : Drug: RAD001 Phase I: Starting dose 5 mg by mouth daily fo |
Completed |
: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 : Human T-Lymphoma Virus Type I : 2006-06-19 |
Withdrawn |
: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia :
: 2010-07-12 : Drug: Velcade IV Other Name: Bortezomib |
Completed |
: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma : Leukemia-Lymphoma, Adult T-Cell : 2009-10-19 :
|